GoAI
Get started
PuraPharm Corporation Limited logo

PuraPharm Corporation Limited

1498.HK

HKSEHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

HK$0.28

HK$0.00 · 0.00%

Aug 20, 2:22 PM HKTData delayed

1498.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
HK
CEO
Yu Ling Chan
Listed since
Jul 8, 2015
Employees
441

Market position

Day range

Current HK$0.28

52-week range

Current HK$0.28

Open
HK$0.275
Previous close
HK$0.28
Volume
76K
0.17× average
Average volume
457.22K
Average daily volume
Market cap
149.82M HKD
Beta
0.2
Market reference 1
50-day average
HK$0.2907
-3.68% below average
200-day average
HK$0.3223
-13.12% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
478.63M HKD
P/E (TTM)
-3.27×
P/B (TTM)
0.95×
P/S (TTM)
0.45×
EV / EBITDA
76.85×
Earnings yield
-23.69%
Free cash flow yield
17.28%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
53.60%
Operating margin
-8.92%
Net margin
-10.48%
Return on equity
-26.99%
Return on assets
-5.08%
Return on invested capital
-6.02%

Financial health

Debt / equity
2.69×
Current ratio
0.47×
Altman Z-score
0.29
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends73%37%0%-36%Gross margin, FY2021: 63.96%Gross margin, FY2022: 58.16%Gross margin, FY2023: 53.24%Gross margin, FY2024: 53.69%Gross margin, FY2025: 53.60%Operating margin, FY2021: 2.67%Operating margin, FY2022: -14.40%Operating margin, FY2023: -12.68%Operating margin, FY2024: -7.70%Operating margin, FY2025: -8.92%Net margin, FY2021: -18.48%Net margin, FY2022: -26.83%Net margin, FY2023: -26.07%Net margin, FY2024: -9.28%Net margin, FY2025: -10.48%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 63.96%. Gross margin FY2022 58.16%. Gross margin FY2023 53.24%. Gross margin FY2024 53.69%. Gross margin FY2025 53.60%. Operating margin FY2021 2.67%. Operating margin FY2022 -14.40%. Operating margin FY2023 -12.68%. Operating margin FY2024 -7.70%. Operating margin FY2025 -8.92%. Net margin FY2021 -18.48%. Net margin FY2022 -26.83%. Net margin FY2023 -26.07%. Net margin FY2024 -9.28%. Net margin FY2025 -10.48%.

Income trends

Revenue

336.11M HKD-12.03%

Operating income

−29.99M HKD-1.94%

Net income

−35.22M HKD+0.61%
Income trends across reported periods737.74M HKD425.15M HKD112.56M HKD−200.02M HKDRevenue, FY2021: 659.59M HKDRevenue, FY2022: 448.07M HKDRevenue, FY2023: 406.86M HKDRevenue, FY2024: 382.09M HKDRevenue, FY2025: 336.11M HKDOperating income, FY2021: 17.62M HKDOperating income, FY2022: −64.5M HKDOperating income, FY2023: −51.58M HKDOperating income, FY2024: −29.42M HKDOperating income, FY2025: −29.99M HKDNet income, FY2021: −121.88M HKDNet income, FY2022: −120.21M HKDNet income, FY2023: −106.08M HKDNet income, FY2024: −35.44M HKDNet income, FY2025: −35.22M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 659.59M HKD. Revenue FY2022 448.07M HKD. Revenue FY2023 406.86M HKD. Revenue FY2024 382.09M HKD. Revenue FY2025 336.11M HKD. Operating income FY2021 17.62M HKD. Operating income FY2022 −64.5M HKD. Operating income FY2023 −51.58M HKD. Operating income FY2024 −29.42M HKD. Operating income FY2025 −29.99M HKD. Net income FY2021 −121.88M HKD. Net income FY2022 −120.21M HKD. Net income FY2023 −106.08M HKD. Net income FY2024 −35.44M HKD. Net income FY2025 −35.22M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue336.11M HKD382.09M HKD406.86M HKD448.07M HKD659.59M HKD
Cost of goods sold155.96M HKD176.95M HKD190.23M HKD187.48M HKD237.74M HKD
Gross profit180.16M HKD205.14M HKD216.63M HKD260.59M HKD421.85M HKD
Research and development13.76M HKD11.17M HKD14.99M HKD22.32M HKD23.95M HKD
Selling, general, and administrative204.54M HKD223.39M HKD263.18M HKD325.84M HKD380.28M HKD
Operating expenses210.14M HKD234.56M HKD282.67M HKD325.09M HKD404.23M HKD
Interest income39K HKD349K HKD293K HKD475K HKD360K HKD
Interest expense20.72M HKD23.71M HKD27.41M HKD24.18M HKD27.03M HKD
Depreciation and amortization22.45M HKD35.59M HKD48.59M HKD48.66M HKD50.14M HKD
Operating income−29.99M HKD−29.42M HKD−51.58M HKD−64.5M HKD17.62M HKD
Net income−35.22M HKD−35.44M HKD−106.08M HKD−120.21M HKD−121.88M HKD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
50%
2 beats, 2 misses, 0 met estimates
Average EPS surprise
-255.45%
4 comparable reports
Latest EPS result
-0.03

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.150.02-0.11-0.24Q3 '22No estimateQ1 '23MissQ3 '23No estimateQ1 '24No estimateQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 28, 2022: actual -0.1, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 21, 2023: actual -0.2, estimate 0.11, surprise -281.82%, Miss. Q3 2023, reported Aug 29, 2023: actual -0.095, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual -0.17, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 28, 2024: actual -0.047, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual -0.042, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 26, 2025: actual -0.055, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 25, 2026: actual -0.03, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates721.83M527.64M333.44M139.25MQ3 '22MissQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 28, 2022: actual 230.76M HKD, estimate 680.5M HKD, surprise -66.09%, Miss. Q1 2023, reported Mar 21, 2023: actual 217.31M HKD, estimate 680.5M HKD, surprise -68.07%, Miss. Q3 2023, reported Aug 29, 2023: actual 195.08M HKD, estimate 680.5M HKD, surprise -71.33%, Miss. Q1 2024, reported Mar 28, 2024: actual 211.78M HKD, estimate 680.5M HKD, surprise -68.88%, Miss. Q3 2024, reported Aug 28, 2024: actual 207.63M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 174.46M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 26, 2025: actual 172.3M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 25, 2026: actual 163.82M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.0191

2017 complete year-77.3% since 2016

Corporate action history

Dividend

Ex-dividend May 31, 2017

HK$0.0202

Annual

Record Jun 1, 2017 · Payment Jun 23, 2017

Dividend

Ex-dividend May 19, 2016

HK$0.084

Annual

Continue in GoAI

Research 1498.HK

research.disclaimer